Solicitation Number: 36C25225Q0249
Date Added: February 12, 2025
Cost per test requirement for FDA-approved or authorized by FDA under an EUA, CLIA-waived, rapid, PCR based, interfaced, point of care analyzers and assays for each of the following: detection of SARS-CoV-2, RSV, and Influenza A & B viruses simultaneously in a nasal swab specimen.
Set-Aside: N/A (N/A)
Place of Performance: N/A, N/A, N/A
NAICS Codes:
334516
Files: